RareLink Implementation Guide
2.0.0 - 2.0.0
RareLink Implementation Guide - Local Development build (v2.0.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
Draft as of 2025-05-12 |
<ValueSet xmlns="http://hl7.org/fhir">
<id value="level-of-evidence-vs"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ValueSet level-of-evidence-vs</b></p><a name="level-of-evidence-vs"> </a><a name="hclevel-of-evidence-vs"> </a><a name="level-of-evidence-vs-en-US"> </a><ul><li>Include these codes as defined in <a href="http://loinc.org"><code>http://loinc.org</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td><a href="https://loinc.org/LA30200-2/">LA30200-2</a></td><td>Very strong evidence pathogenic</td></tr><tr><td><a href="https://loinc.org/LA30201-0/">LA30201-0</a></td><td>Strong evidence pathogenic</td></tr><tr><td><a href="https://loinc.org/LA30202-8/">LA30202-8</a></td><td>Moderate evidence pathogenic</td></tr><tr><td><a href="https://loinc.org/LA30203-6/">LA30203-6</a></td><td>Supporting evidence pathogenic</td></tr><tr><td><a href="https://loinc.org/LA30204-4/">LA30204-4</a></td><td>Supporting evidence benign</td></tr><tr><td><a href="https://loinc.org/LA30205-1/">LA30205-1</a></td><td>Strong evidence benign</td></tr><tr><td><a href="https://loinc.org/LA30206-9/">LA30206-9</a></td><td>Stand-alone evidence pathogenic</td></tr></table></li></ul></div>
</text>
<url
value="https://rarelink.bih-charite.de/fhir/ValueSet/level-of-evidence-vs"/>
<version value="2.0.0"/>
<name value="LevelOfEvidenceVS"/>
<title value="Level of Evidence Value Set"/>
<status value="draft"/>
<date value="2025-05-12T08:03:20+00:00"/>
<publisher
value="Berlin Institute of Health - Charité Universitätsmedizin Berlin"/>
<contact>
<name
value="Berlin Institute of Health - Charité Universitätsmedizin Berlin"/>
<telecom>
<system value="url"/>
<value value="https://github.com/BIH-CEI/RareLink"/>
</telecom>
<telecom>
<system value="email"/>
<value value="adam.graefe@charite.de"/>
</telecom>
</contact>
<description
value="LOINC LA codes describing evidence strength for a variant."/>
<compose>
<include>
<system value="http://loinc.org"/>
<concept>
<code value="LA30200-2"/>
<display value="Very strong evidence pathogenic"/>
</concept>
<concept>
<code value="LA30201-0"/>
<display value="Strong evidence pathogenic"/>
</concept>
<concept>
<code value="LA30202-8"/>
<display value="Moderate evidence pathogenic"/>
</concept>
<concept>
<code value="LA30203-6"/>
<display value="Supporting evidence pathogenic"/>
</concept>
<concept>
<code value="LA30204-4"/>
<display value="Supporting evidence benign"/>
</concept>
<concept>
<code value="LA30205-1"/>
<display value="Strong evidence benign"/>
</concept>
<concept>
<code value="LA30206-9"/>
<display value="Stand-alone evidence pathogenic"/>
</concept>
</include>
</compose>
</ValueSet>